Targeting SWI/SNF mutant cancers with tyrosine kinase inhibitor therapy. (2017)
Attributed to:
A toolkit for tyrosine kinase signalling network analysis.
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1080/14737140.2017.1257941
PubMed Identifier: 27819171
Publication URI: http://europepmc.org/abstract/MED/27819171
Type: Journal Article/Review
Volume: 17
Parent Publication: Expert review of anticancer therapy
Issue: 1
ISSN: 1473-7140